Rhenium-Skin Cancer Therapy (SCT) for the Treatment of Non-Melanoma Skin

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04103658` - NIR and Skin Cancer Margins	N/A
Completed	`NCT01053819` - Can We Miss Pigmented Lesions in Psoriasis Patients?	Phase 4
Recruiting	`NCT03767348` - Study of RP1 Monotherapy and RP1 in Combination With Nivolumab	Phase 2
Recruiting	`NCT05429866` - Immunological Variables Associated to ICI Toxicity in Cancer Patients	Phase 2
Active, not recruiting	`NCT02636569` - Topical Chemoprevention of Skin Cancer Biomarkers	Phase 2
Completed	`NCT02760160` - Dietary Prevention of Photodamage in Skin With Grapes	N/A
Completed	`NCT02780934` - Comparing Pressure Versus Simple Adhesive Dressing After Mohs Reconstruction	N/A
Completed	`NCT02872909` - Randomized Comparison of Low and Conventional Irradiance PDT for Skin Cancer	N/A
Withdrawn	`NCT03327064` - A Biomarker Evaluation Trial of UAB30 in Renal Transplant Recipients at High Risk for Non-melanoma Skin Cancer	Phase 1/Phase 2
Completed	`NCT00342407` - The Incidence of Breast and Other Cancers Among Female Flight Attendants
Terminated	`NCT04410874` - Imvamune Vaccine for the Treatment of Non-melanoma Skin Cancer	Phase 1/Phase 2
Completed	`NCT03693937` - A Retrospective Evaluation of Superficial Radiation Therapy (SRT) and Non-Melanoma Skin Cancer (NMSC)
Completed	`NCT04334824` - Hydrochlorothiazide and Risk of Skin Cancer
Recruiting	`NCT05878288` - Deep sequencIng in Cutaneous Squamous CEll caRciNomas	Phase 2
Completed	`NCT01359735` - Healing Effects of HP802-247 Versus Antibiotic Ointment in Mohs Micrographic Surgery Patients	Phase 2
Terminated	`NCT04348916` - Study of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Solid Tumors	Phase 1
Enrolling by invitation	`NCT05257486` - Post-market Multi-Center RETRO-Prospective Study to Assess Long-term Clinical Outcomes NMSC Patients Treated With eBx
Withdrawn	`NCT03757663` - UV Dosimetry Feedback in NMSC Patients	N/A
Completed	`NCT04116983` - DERM NMSC Validation Study
Active, not recruiting	`NCT06227416` - Skin Tumor Biomarkers by Mass Spectrometry Imaging	N/A

NCT number	NCT05135052
Study type	Interventional
Source	OncoBeta International GmbH
Contact	Gerhard Dr Dahlhoff, MD
Phone	08136808989
Email	gerhard.dahlhoff@oncobeta.com
Status	Recruiting
Phase	N/A
Start date	January 17, 2022
Completion date	May 15, 2024

Rhenium-Skin Cancer Therapy (SCT) for the Treatment of Non-Melanoma Skin Cancer. — EPIC-Skin

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms